AI assistant
Sending…
RESMED INC — Director's Dealing 2011
Nov 18, 2011
30071_dirs_2011-11-18_580d377d-31a7-49b4-8173-7c026fd6c0a0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2011-11-16
Reporting Person: PENDARVIS DAVID (Chief Administrative Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-11-16 | ResMed Common Stock Options | $27.58 | A | 80000 | Acquired | 2018-11-16 | ResMed Common Stock (80000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 128410.086 | Direct |
Footnotes
F1: Represents date options first become available. Options vest 1/4 annually until fully vested.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29